Is radioiodine ablation with 1.1 GBq (30 mCi) 131I necessary in low-risk thyroid cancer patients? Results from a long-term follow-up prospective study
V Ilera, I Califano, A Cavallo, E Faure, A Vázquez… - Endocrine, 2023 - Springer
Background In patients with low-risk differentiated thyroid cancer (DTC), remnant ablation
with radioiodine (RA) after total thyroidectomy (TT) is controversial. No benefits have been …
with radioiodine (RA) after total thyroidectomy (TT) is controversial. No benefits have been …
[HTML][HTML] Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real …
A Campennì, RM Ruggeri, ML Garo, M Siracusa… - Cancers, 2023 - mdpi.com
Simple Summary The aim of the present study was to retrospectively evaluate the efficacy of
low (1.1 GBq) versus moderate (2.2 GBq) 131I activities in a large series (n= 299) of low-risk …
low (1.1 GBq) versus moderate (2.2 GBq) 131I activities in a large series (n= 299) of low-risk …
Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low‐risk well‐differentiated thyroid cancer
S Tsirona, V Vlassopoulou, M Tzanela… - Clinical …, 2014 - Wiley Online Library
Objective Postoperative radioiodine remnant ablation (RRA) represents an adjunctive
therapeutic modality in patients with differentiated thyroid cancer (DTC). The impact of late …
therapeutic modality in patients with differentiated thyroid cancer (DTC). The impact of late …
[HTML][HTML] 99mTc-pertechnetate scintigraphy predicts successful postoperative ablation in differentiated thyroid carcinoma patients treated with low radioiodine activities
L Giovanella, G Paone, T Ruberto… - Endocrinology and …, 2019 - ncbi.nlm.nih.gov
Background Postoperative routine radioiodine (RAI) treatment is currently debated for
patients with low-risk differentiated thyroid carcinoma (DTC) patients. If performed, a low 131 …
patients with low-risk differentiated thyroid carcinoma (DTC) patients. If performed, a low 131 …
Delayed 131-I first treatment after surgery has no impact on the median term outcome of patients with intermediate risk differentiated thyroid cancer
Objective: In intermediate risk (IR) differentiated thyroid cancer (DTC) patients, selective use
of radioiodine (131-I) for remnant ablation and/or as adjuvant therapy (RRA) is advocated …
of radioiodine (131-I) for remnant ablation and/or as adjuvant therapy (RRA) is advocated …
Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial
Objectives Radioiodine ablation of thyroid tissue remains the cornerstone of treatment for
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose …
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose …
Outcomes after radioiodine ablation in patients with thyroid cancer: Long‐term follow‐up of a Chinese randomized clinicaltrial
P Dong, Y Qu, L Yang, L Xiao, R Huang… - Clinical …, 2021 - Wiley Online Library
Objective Two large randomized trials of patients with differentiated thyroid cancer (DTC)
reported recently (HiLo and ESTIMABL1) found that the recurrence rate among patients who …
reported recently (HiLo and ESTIMABL1) found that the recurrence rate among patients who …
Comparison between the different doses of radioactive iodine ablation prescribed in patients with intermediate-to-high-risk differentiated thyroid cancer
Y Iizuka, T Katagiri, K Ogura, T Mizowaki - Annals of Nuclear Medicine, 2019 - Springer
Objective This study aimed to compare the clinical outcomes of patients who received
radioactive iodine (RAI) ablation after undergoing thyroidectomy for intermediate-to-high-risk …
radioactive iodine (RAI) ablation after undergoing thyroidectomy for intermediate-to-high-risk …
Applying postoperative radioiodine therapy before 3 months seems to decrease ablation success in patients with differentiated thyroid carcinoma
Objectives Radioiodine can be applied for remnant ablation in low and low to intermediate-
risk patients with differentiated thyroid cancer (DTC). A controversy still exists about the …
risk patients with differentiated thyroid cancer (DTC). A controversy still exists about the …
Radioiodine remnant ablation in low‐risk differentiated thyroid cancer patients who had R0 dissection is an over treatment
C Bal, S Ballal, R Soundararajan, S Chopra… - Cancer …, 2015 - Wiley Online Library
Low‐risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit,
with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC …
with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC …